Latest news
Eli Lilly Makes Another Biotech Bet Ahead Of Retatrutide Data – LLY Stock Surges To Highest In Over 2 Months - StocktwitsStocktwits · Sat, 08 Aug 2026 08:49:38 GMTEli Lilly Announces New Version Of Zepbound With A Month’s Worth Of Doses In KwikPen — How Much Will It Cost? - StocktwitsStocktwits · Sat, 08 Aug 2026 03:23:49 GMTHims & Hers Adds Lilly GLP-1 Treatments To Lineup – CEO Compares It To Netflix’s Early Days - StocktwitsStocktwits · Fri, 07 Aug 2026 20:34:38 GMTLLY Shares Dive On Analyst Downgrade Citing Obesity Market Overestimation Concerns, But Retail Dismisses ‘Absurd’ Selloff - StocktwitsStocktwits · Fri, 07 Aug 2026 13:53:45 GMTNovo's 'Flashy' Ozempic, Wegovy Price Cuts Unlikely To Impact LLY Stock, Says BofA - StocktwitsStocktwits · Fri, 07 Aug 2026 11:05:21 GMTLLY Stock Slides Toward Sixth Weekly Loss, But 200-DMA Holds Firm: Is It Setting Up For Earnings Run? - StocktwitsStocktwits · Fri, 07 Aug 2026 05:45:01 GMTLLY Vs. NVO: Whose Oral Obesity Drug Had Better Launch Reception? - StocktwitsStocktwits · Fri, 07 Aug 2026 04:42:01 GMTLLY Stock Hits All-Time High — Is CVS Coverage Boost For Zepbound Driving Gains? - StocktwitsStocktwits · Fri, 07 Aug 2026 01:19:35 GMT